Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP715140.RAac5JKBLSQjr4KODV1UKTjf18pEUWp47-svPyOwAp86w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP715140.RAac5JKBLSQjr4KODV1UKTjf18pEUWp47-svPyOwAp86w130_assertion type Assertion NP715140.RAac5JKBLSQjr4KODV1UKTjf18pEUWp47-svPyOwAp86w130_head.
- NP715140.RAac5JKBLSQjr4KODV1UKTjf18pEUWp47-svPyOwAp86w130_assertion description "[Herein, we show that in vivo administration of all-trans-retinoic acid (ATRA) or the histone deacetylase inhibitor sodium valproate (VPA) to patients affected with acute myeloid leukaemia (AML) M3 or M1 respectively, leads to the induction of transcription and expression of NKG2D-L at the surface of leukaemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715140.RAac5JKBLSQjr4KODV1UKTjf18pEUWp47-svPyOwAp86w130_provenance.
- NP715140.RAac5JKBLSQjr4KODV1UKTjf18pEUWp47-svPyOwAp86w130_assertion evidence source_evidence_literature NP715140.RAac5JKBLSQjr4KODV1UKTjf18pEUWp47-svPyOwAp86w130_provenance.
- NP715140.RAac5JKBLSQjr4KODV1UKTjf18pEUWp47-svPyOwAp86w130_assertion SIO_000772 19151770 NP715140.RAac5JKBLSQjr4KODV1UKTjf18pEUWp47-svPyOwAp86w130_provenance.
- NP715140.RAac5JKBLSQjr4KODV1UKTjf18pEUWp47-svPyOwAp86w130_assertion wasDerivedFrom befree-2016 NP715140.RAac5JKBLSQjr4KODV1UKTjf18pEUWp47-svPyOwAp86w130_provenance.
- NP715140.RAac5JKBLSQjr4KODV1UKTjf18pEUWp47-svPyOwAp86w130_assertion wasGeneratedBy ECO_0000203 NP715140.RAac5JKBLSQjr4KODV1UKTjf18pEUWp47-svPyOwAp86w130_provenance.